20-35115899-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_018217.3(EDEM2):c.1271G>A(p.Arg424His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000062 ( 0 hom. )
Consequence
EDEM2
NM_018217.3 missense
NM_018217.3 missense
Scores
11
4
4
Clinical Significance
Conservation
PhyloP100: 7.73
Genes affected
EDEM2 (HGNC:15877): (ER degradation enhancing alpha-mannosidase like protein 2) In the endoplasmic reticulum (ER), misfolded proteins are retrotranslocated to the cytosol and degraded by the proteasome in a process known as ER-associated degradation (ERAD). EDEM2 belongs to a family of proteins involved in ERAD of glycoproteins (Mast et al., 2005 [PubMed 15537790]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.881
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDEM2 | NM_018217.3 | c.1271G>A | p.Arg424His | missense_variant | 11/11 | ENST00000374492.8 | NP_060687.2 | |
EDEM2 | NM_001145025.2 | c.1160G>A | p.Arg387His | missense_variant | 10/10 | NP_001138497.1 | ||
MMP24-AS1-EDEM2 | NM_001355008.2 | c.1148G>A | p.Arg383His | missense_variant | 15/15 | NP_001341937.1 | ||
EDEM2 | NR_026728.2 | n.1565G>A | non_coding_transcript_exon_variant | 10/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDEM2 | ENST00000374492.8 | c.1271G>A | p.Arg424His | missense_variant | 11/11 | 1 | NM_018217.3 | ENSP00000363616.3 | ||
EDEM2 | ENST00000374491.3 | c.1160G>A | p.Arg387His | missense_variant | 10/10 | 1 | ENSP00000363615.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152106Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152106
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461814Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727194
GnomAD4 exome
AF:
AC:
9
AN:
1461814
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74302
GnomAD4 genome
AF:
AC:
1
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74302
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Maturity onset diabetes mellitus in young Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Medical Genomics Research Department, King Abdullah International Medical Research Center | Nov 01, 2019 | The Arg424His variant in EDEM2 located in a highly conserved amino acid region with arginine conserved up to Saccharomyces cerevisiae. Prediction software SIFT, PolyPhen-2, PROVEAN and PhD-SNP predicted the variant to be deleterious. Additionally, in vitro functional studies indicate that the EDEM2 disruption reduces the expression of beta-cell genes involved in the glucose-stimulated insulin secretion (GSIS) pathway leading to an overall suppression of insulin secretion. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Loss of stability (P = 0.0603);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at